Once-Weekly Semaglutide in Adolescents with Obesity | NEJM
Semaglutide in teenagers with obesity
Semaglutide in teenagers with obesity
As we turn the page on 2023, we here at JAMA Neurology want to once again thank all of our readers, authors, and peer reviewers…
sults from it is still unclear. It is also unclear to what extent autonomic hyperactivation is related to experienced pain intensity in different subtypes or…
s placebos, have been proposed as an ethically acceptable alternative. Early studies have suggested that OLP can improve pain outcomes, but important questions remain as…
Gossamer Bio said on Monday it will collaborate with Chiesi Group to develop and commercialize its drug seralutinib in multiple indications related to blood pressure…
Browse more than 190 digital films, covering surgical techniques, research advancements, clinical updates, and more. On-demand films are organized by primary clinical category below. Winning…
The conference is the premier boutique healthcare investment event in the U.S. and is scheduled for May 21-22 in Chicago at the Ritz Carlton hotel.
Shah et al. describe an approach to measure single-neuronal excitability at large scale in a mouse model of epilepsy in vivo and show that neuronal excitability is…
A new Florida law prohibits many Chinese citizens from buying homes because of national security concerns. Critics say it has fueled discrimination and chilled the…
Application based on results from CheckMate -67T, the first Phase 3 trial of the subcutaneous formulation of nivolumab to evaluate and demonstrate noninferior pharmacokinetics, efficacy…
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence…